Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAF V600E clone in a newborn affected by high-risk Langerhans cell histiocytosis.

Details

Language :

English

ISSN :

1365-2141

Volume :

205

Issue :

3

Database :

MEDLINE

Journal :

British journal of haematology

Publication Type :

Editorial & Opinion

Accession number :

38986479

Full Text :

https://doi.org/10.1111/bjh.19637